ReviewNutrients2026
Chlorella Growth Factor: Biochemical Identity, Redox-Active Mechanisms, Nutritional Relevance, and Translational Implications.
Review in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chlorella Growth Factor (CGF) is a nucleotide-rich, water-soluble intracellular fraction derived from disrupted Chlorella biomass that has historically been described as a "growth-promoting" extract but remains poorly defined at the molecular level. In this review, we propose that CGF should not be interpreted as a classical receptor-binding growth factor, but rather as a heterogeneous, nucleotide-dominant metabolic fraction that may modulate cellular redox balance and biosynthetic capacity. We integrate available evidence on CGF characterization, including A260-based analytical indices, mineral-dependent biosynthesis, and extraction methodologies, with mechanistic observations from in vitro, animal, and applied biological systems. Across these contexts, CGF-associated fractions have been reported to influence redox-sensitive pathways, including NAD(H)/NADP(H)-linked processes, MAPK/AP-1 signaling, extracellular matrix regulation, and humoral immune responses. However, most mechanistic evidence remains indirect, and compositional heterogeneity limits direct comparability across studies. From a nutritional perspective, CGF contributes minimal macronutrient value but may provide conditionally relevant dietary nucleotides, amino acids, and redox-active metabolites that support metabolic processes under stress conditions. Observed biological effects are consistent with a model of metabolic permissiveness, in which CGF-associated fractions may support endogenous cellular functions rather than directly initiating signaling cascades. Key translational challenges include the lack of compositional standardization, limited nucleotide speciation, variability in extraction protocols, and the absence of pharmacokinetic and controlled human studies using well-characterized CGF preparations. Overall, CGF may be conceptualized as a candidate dietary bioactive with redox-centered and metabolically permissive properties. Further work integrating standardized analytical frameworks with mechanistic and clinical validation will be required to establish its role in human nutrition and functional food applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.